University Hospital Liège
Welcome,         Profile    Billing    Logout  
 24 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Beguin, Yves
Predictor2, NCT03887156: Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft

Recruiting
2/3
227
Europe
Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
Assistance Publique - Hôpitaux de Paris, SATT, SNC Graft Versus Host Disease, Imagine Institute, Axonal-Biostatem, CERBA laboratory
Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome, Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts, Acute Leukemia Biphenotypic in Remission, Acute Lymphoblastic Leukemia
03/23
03/23
Willems, Evelyne
ARES, NCT04769895 / 2021-001841-11: MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients

Active, not recruiting
3
66
Europe
MaaT013
MaaT Pharma, MaaT Pharma
Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD
11/24
11/25
ROCKnrol-1, NCT06143891: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Recruiting
3
260
Europe, Canada, US, RoW
Belumosudil, SAR445761/ KD025, REZUROCK, Placebo, Prednisone, Prednisolone
Sanofi
Chronic Graft Versus Host Disease
09/28
09/28
Baron, Frédéric
NCT04951323: Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Recruiting
3
50
Europe
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer), COVID-19 mRNA Vaccine, Pfizer
University of Liege, Pfizer
Coronavirus Disease 2019 (Covid19), Hematopoietic Neoplasms
12/22
01/23
Predictor2, NCT03887156: Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft

Recruiting
2/3
227
Europe
Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
Assistance Publique - Hôpitaux de Paris, SATT, SNC Graft Versus Host Disease, Imagine Institute, Axonal-Biostatem, CERBA laboratory
Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome, Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts, Acute Leukemia Biphenotypic in Remission, Acute Lymphoblastic Leukemia
03/23
03/23
Louis, Edouard
FREE, NCT04646187 / 2020-001811-26: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

Enrolling by invitation
4
148
Europe
Infliximab, Remicade, Flixabi, Inflectra, Remsima, Zessly, Adalimumab, Humira, AMGEVITA, Hulio, Hyrimoz, Idacio, Imraldi
University Medical Center Groningen, European Crohn´s and Colitis Organisation, Bühlmann Laboratories AG
Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
03/26
03/26
SOCRATES, NCT04089345: Stelara fOr ChRonic AntibioTic rEfractory pouchitiS

Completed
3
20
Europe
Ustekinumab, Stelara
Universitaire Ziekenhuizen KU Leuven, Janssen Pharmaceuticals
Pouchitis
12/22
05/23
Humblet-Baron, Stéphanie
No trials found
Hannon, Muriel
No trials found
Malaise, Olivier
No trials found

Download Options